Literature DB >> 9445133

Clinical and pathological features of breast disease in Cowden's syndrome: an underrecognized syndrome with an increased risk of breast cancer.

C A Schrager1, D Schneider, A C Gruener, H C Tsou, M Peacocke.   

Abstract

Cowden's syndrome (CS), or multiple hamartoma syndrome, is an autosomal dominant disorder associated with benign skin tumors and an increased risk of breast cancer. In an effort to understand the basic mechanisms regulating the development of breast cancer in this patient population, as well as to define diagnostic aspects of the disorder, we describe for the first time the clinical and pathological spectrum of breast disease in CS. We obtained the clinical histories and examined the histopathology of 59 cases from 19 women with CS sent to us from a variety of institutions. The 19 women showed a spectrum of benign histopathological findings, including ductal hyperplasia, intraductal papillomatosis, adenosis, lobular atrophy, fibroadenomas, and fibrocystic change. Seventeen (89%) showed features suggestive of a breast hamartoma. Fourteen women (74%) showed malignant disease, most of which was ductal carcinoma. Twelve patients (86%) showed ductal carcinoma in situ (DCIS), and 12 (86%) showed infiltrating ductal carcinoma. One patient had only DCIS and another patient showed both infiltrating tubular carcinoma and lobular carcinoma in situ. Ten patients (71%) actually showed foci of tumor involving densely fibrotic, hamartomatous areas. In summary, we show that women with CS have a spectrum of exuberant benign and malignant breast pathology. A common benign breast lesion in CS is a densely fibrotic hyalinized nodule, whereas the most frequent breast malignancy is ductal carcinoma.

Entities:  

Mesh:

Year:  1998        PMID: 9445133     DOI: 10.1016/s0046-8177(98)90389-6

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  30 in total

1.  Cowden syndrome: mucocutaneous lesions as precursors of internal malignancy.

Authors:  Panagiotis Stathopoulos; Anna Raymond; Michael Esson
Journal:  Oral Maxillofac Surg       Date:  2014-04-01

2.  Cowden syndrome.

Authors:  Abderrahmen Masmoudi; Zied Mohamed Chermi; Slaheddine Marrekchi; Ben Salah Raida; Sonia Boudaya; Madiha Mseddi; Meziou Taha Jalel; Hamida Turki
Journal:  J Dermatol Case Rep       Date:  2011-03-26

3.  Evaluation of breast involvement in relation to Cowden syndrome: a radiological and clinicopathological study of patients with PTEN germ-line mutations.

Authors:  Josep M Sabaté; Antonio Gómez; Sofía Torrubia; Carme Blancas; Gloria Sánchez; M C Alonso; E Lerma
Journal:  Eur Radiol       Date:  2005-10-06       Impact factor: 5.315

4.  Male breast cancer in Cowden syndrome patients with germline PTEN mutations.

Authors:  J D Fackenthal; D J Marsh; A L Richardson; S A Cummings; C Eng; B G Robinson; O I Olopade
Journal:  J Med Genet       Date:  2001-03       Impact factor: 6.318

5.  Mosaic partial deletion of the PTEN gene in a patient with Cowden syndrome.

Authors:  Erin E Salo-Mullen; Jinru Shia; Isaac Brownell; Peter Allen; Monica Girotra; Mark E Robson; Kenneth Offit; Jose G Guillem; Arnold J Markowitz; Zsofia K Stadler
Journal:  Fam Cancer       Date:  2014-09       Impact factor: 2.375

Review 6.  Inhibiting PI3K as a therapeutic strategy against cancer.

Authors:  Luis Paz-Ares; Carmen Blanco-Aparicio; Rocío García-Carbonero; Amancio Carnero
Journal:  Clin Transl Oncol       Date:  2009-09       Impact factor: 3.405

7.  Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models.

Authors:  Carmen Blanco-Aparicio; Marta Cañamero; Yolanda Cecilia; Belén Pequeño; Oliver Renner; Irene Ferrer; Amancio Carnero
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

8.  Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.

Authors:  Guillaume Banneau; Mickaël Guedj; Gaëtan MacGrogan; Isabelle de Mascarel; Valerie Velasco; Renaud Schiappa; Valerie Bonadona; Albert David; Catherine Dugast; Brigitte Gilbert-Dussardier; Olivier Ingster; Pierre Vabres; Frederic Caux; Aurelien de Reynies; Richard Iggo; Nicolas Sevenet; Françoise Bonnet; Michel Longy
Journal:  Breast Cancer Res       Date:  2010-08-16       Impact factor: 6.466

Review 9.  PTEN hamartoma tumor syndromes.

Authors:  Gideon M Blumenthal; Phillip A Dennis
Journal:  Eur J Hum Genet       Date:  2008-09-10       Impact factor: 4.246

10.  The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation.

Authors:  Thomas Holbro; Roger R Beerli; Francisca Maurer; Magdalena Koziczak; Carlos F Barbas; Nancy E Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.